Case fatality of COPD exacerbations: A meta-analysis and statistical modelling approach

European Respiratory Journal

Volumn 37, Issue 3, 2011, Pages 508-515

  Hoogendoorn, M ^a   Hoogenveen, R T ^b   Rutten van Molken M P ^a   Vestbo, J ^d,e   Feenstra, T L ^b,c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Case fatality; Chronic obstructive pulmonary disease; Exacerbation; Hospitalisation; Meta analysis

Indexed keywords

AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; ONSET AGE; PRIORITY JOURNAL; STATISTICAL MODEL; SURVIVAL TIME; SYSTEMATIC REVIEW;

AGED; FEMALE; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; STATISTICS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953674776     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00043710     Document Type: Article

References (29)

1. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412. (Pubitemid 43180921)
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
3. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239. (Pubitemid 40216240)
4. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012. (Pubitemid 38269277)
5. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416-469.
6. Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997; 52: 43-47. (Pubitemid 27232210)
7. Stevens RJ, Coleman RL, Adler AI, et al. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 2004; 27: 201-207. (Pubitemid 38196733)
8. Faustini A, Marino C, D'Ippoliti D, et al. The impact on risk-factor analysis of different mortality outcomes in COPD patients. Eur Respir J 2008; 32: 629-636.
9. Patil SP, Krishnan JA, Lechtzin N, et al. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163: 1180-1186. (Pubitemid 36613070)
10. Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98: 272-277.
11. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-1857. (Pubitemid 26001261)
12. Feenstra TL, Van Genugten ML, Hoogenveen RT, et al. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001; 164: 590-596. (Pubitemid 32801662)
13. Hoogendoorn M, Rutten-van Molken MP, Hoogenveen RT, et al. A dynamic population model of disease progression in COPD. Eur Respir J 2005; 26: 223-233. (Pubitemid 41079065)
14. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. (Pubitemid 17189972)
15. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959-967.
16. Vestbo J, Prescott E, Lange P, et al. Vital prognosis after hospitalization for COPD: a study of a random population sample. Respir Med 1998; 92: 772-776.
17. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467. (Pubitemid 37000120)
18. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005; 26: 234-241. (Pubitemid 41079066)
19. McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007; 132: 1748-1755.
20. Brekke PH, Omland T, Holmedal SH, et al. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 2008; 31: 563-570.
21. Cydulka RK, McFadden ER Jr, Emerman CL, et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 1807-1812. (Pubitemid 28011786)
22. Eriksen N, Hansen EF, Munch EP, et al. [Chronic obstructive pulmonary disease. Admission, course and prognosis]. Ugeskr Laeger 2003; 165: 3499-3502.
23. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34: 491-496. (Pubitemid 41282855)
24. Wang Q, Bourbeau J. Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD. Respirology 2005; 10: 334-340. (Pubitemid 41025611)
25. Price LC, Lowe D, Hosker HS, et al. UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006; 61: 837-842. (Pubitemid 44570302)
26. Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falco M, et al. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 2007; 25: 515-522. (Pubitemid 46818847)
27. Kinnunen T, Saynajakangas O, Keistinen T. Features of hospitalisations for acute exacerbation of COPD resulting in death. Monaldi Arch Chest Dis 2007; 67: 10-14. (Pubitemid 46840066)
28. Dransfield MT, Rowe SM, Johnson JE, et al. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008; 63: 301-305. (Pubitemid 351497940)
29. Eriksen N, Vestbo J. Management and survival of patients admitted with an exacerbation of COPD: Comparison of two Danish patient cohorts. Clin Respir J 2010; 4: 208-214.